首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1261041篇
  免费   96779篇
  国内免费   1580篇
耳鼻咽喉   16369篇
儿科学   40995篇
妇产科学   35066篇
基础医学   188670篇
口腔科学   34913篇
临床医学   117564篇
内科学   247076篇
皮肤病学   27383篇
神经病学   101477篇
特种医学   46980篇
外国民族医学   265篇
外科学   179054篇
综合类   25731篇
现状与发展   3篇
一般理论   570篇
预防医学   103988篇
眼科学   28135篇
药学   92772篇
  6篇
中国医学   1958篇
肿瘤学   70425篇
  2018年   13628篇
  2017年   10490篇
  2016年   11440篇
  2015年   13183篇
  2014年   18135篇
  2013年   27677篇
  2012年   37878篇
  2011年   40279篇
  2010年   23228篇
  2009年   22434篇
  2008年   38065篇
  2007年   40721篇
  2006年   40272篇
  2005年   39441篇
  2004年   37873篇
  2003年   36202篇
  2002年   35072篇
  2001年   56196篇
  2000年   57152篇
  1999年   47975篇
  1998年   12540篇
  1997年   11373篇
  1996年   11773篇
  1995年   11887篇
  1994年   11095篇
  1993年   10370篇
  1992年   38355篇
  1991年   37866篇
  1990年   36644篇
  1989年   35442篇
  1988年   32827篇
  1987年   32151篇
  1986年   30641篇
  1985年   28885篇
  1984年   21978篇
  1983年   19206篇
  1982年   11329篇
  1981年   10302篇
  1979年   20944篇
  1978年   15383篇
  1977年   12754篇
  1976年   11804篇
  1975年   12804篇
  1974年   15588篇
  1973年   15376篇
  1972年   14547篇
  1971年   13587篇
  1970年   12799篇
  1969年   12119篇
  1968年   11263篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Aristodemou  E.  Retzepi  M.  Calciolari  E.  Donos  N. 《Clinical oral investigations》2022,26(8):5223-5235
Clinical Oral Investigations - To evaluate the effect of membrane occlusiveness and experimental diabetes on early and late healing following guided bone regeneration. A total of 30 Wistar rats...  相似文献   
3.
4.
Objective: Hepatocellular carcinoma (HCC) microenvironment has been recognized as a key contributor for cancer progression, metastasis, and drug resistance. The crosstalk between tumor cells, the vascular endothelial growth factor (VEGF), and the chemokine (C-C motif) ligand 2 (CCL2) signaling networks mediates immunoinhibitory impact and facilitates tumor angiogenesis. The current investigation aimed at exploring the potent anti-cancer activity of the newly designed nano-based anti-cancer therapy comprising anti-VEGF drug, avastin (AV), and CCR2 antagonist (CR) to counteract HCC and tracking its mode of action in vivo. Methods: The prepared AV, CR, and AVCR nanoprototypes were characterized by nanoscale characterization techniques in our previous work. Here, they are applied for unearthing their anti-cancer properties / mechanisms in hepatic cancer-induced rats via analyzing protein levels and genetic expression of the elements incorporated in the angiogenesis, apoptosis, and metastasis signalling pathways. Results: The present results revealed a significant down-regulation in the angiogenesis, survival and metastasis indices along with up-regulation in the pro-apoptotic mediators upon treatment of hepatic cancer-bearing rats with the novel synthesized nanomaterials when compared with the untreated counterparts. We showed across HCC model that anti-VEGF in combination with CCR2 antagonism therapy leads to sensitization and enhanced tumor response over anti-VEGF or CCR2 antagonism monotherapy, particularly in its nanoscale formulation. Conclusion: The present approach provides new mechanistic insights into the powerful anti-hepatic cancer advantage of the novel nanoprototypes which is correlated with modulating critical signal transduction pathways implicated in tumor microenviroment such as angiogenesis, apoptosis and metastasis. This research work presents a substantial foundation for future studies focused on prohibiting cancer progression and recovery by targeting tumor microenviroment.  相似文献   
5.
Whether the underlying mutations are homozygous, heterozygous, or co-inherited with other hemoglobinopathies, sickle cell disease is known to afflict the kidneys, leading to the clinical entity known as sickle cell nephropathy (SCN). Although common, SCN remains diagnostically elusive. Conventional studies performed in the context of renal disorders often fail to detect early stage SCN. This makes the quest for early diagnosis and treatment more challenging, and it increases the burden of chronic kidney disease-related morbidity among patients. Novel diagnostic tools have been employed to overcome this limitation. In this study, we discuss various biomarkers of SCN, including those employed in clinical practice and others recently identified in experimental settings, such as markers of vascular injury, endothelial dysfunction, tubulo-glomerular damage, and oxidative stress. These include kidney injury molecule-1, monocyte chemoattractant protein-1, N-acetyl-B-D-glucosaminidase, ceruloplasmin, orosomucoid, nephrin, and cation channels, among others. Furthermore, we explore the potential of novel biomarkers for refining diagnostic and therapeutic approaches and describe some obstacles that still need to be overcome. We highlight the importance of a collaborative approach to standardize the use of promising new biomarkers. Finally, we outline the limitations of conventional markers of renal damage as extensions of the pathogenic process occurring at the level of the organ and its functional subunits, with a discussion of the expected pattern of clinical and biochemical progression among patients with SCN.  相似文献   
6.
7.
8.
9.
Bulletin of Experimental Biology and Medicine - The psychopharmacological effects of a stimulator of functions of progenitor cells of the nervous tissue STAT3 inhibitor (STAT3 Inhibitor XIV, LLL12)...  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号